Skip to content
MedsAcross

Brand family

Yusimry

Adalimumab · Meitheal Pharmaceuticals
United States
Presentations
2
Markets
1

Yusimry is a brand of Adalimumab marketed by Meitheal Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Adalimumab
Brand owner
Meitheal Pharmaceuticals
Registered in
United States
Strengths and forms
40 mg/0.4 mL injection, 80 mg/0.8 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Yusimry 40 mg/0.4 mL injectionSubcutaneous Cold chainMeitheal PharmaceuticalsUS FDAAvailable on request
Yusimry 80 mg/0.8 mL injectionSubcutaneous Cold chainMeitheal PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Adalimumab.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Yusimry

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.